BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17400928)

  • 21. ERp46 is reduced by high glucose and regulates insulin content in pancreatic beta-cells.
    Alberti A; Karamessinis P; Peroulis M; Kypreou K; Kavvadas P; Pagakis S; Politis PK; Charonis A
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E812-21. PubMed ID: 19622788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D2 is sufficient to drive β cell self-renewal and regeneration.
    Tschen SI; Zeng C; Field L; Dhawan S; Bhushan A; Georgia S
    Cell Cycle; 2017; 16(22):2183-2191. PubMed ID: 28763258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing β-cell mass requires additional stimulation for adaptation to secretory demand.
    Mondal P; Song WJ; Li Y; Yang KS; Hussain MA
    Mol Endocrinol; 2015 Jan; 29(1):108-20. PubMed ID: 25387052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-Cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome.
    Fransson L; Franzén S; Rosengren V; Wolbert P; Sjöholm Å; Ortsäter H
    J Endocrinol; 2013 Dec; 219(3):231-41. PubMed ID: 24048967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse.
    Lu J; Hamze Z; Bonnavion R; Herath N; Pouponnot C; Assade F; Fontanière S; Bertolino P; Cordier-Bussat M; Zhang CX
    Oncogene; 2012 Aug; 31(31):3647-54. PubMed ID: 22120711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clock gene Rev-erbα regulates pancreatic β-cell function: modulation by leptin and high-fat diet.
    Vieira E; Marroquí L; Batista TM; Caballero-Garrido E; Carneiro EM; Boschero AC; Nadal A; Quesada I
    Endocrinology; 2012 Feb; 153(2):592-601. PubMed ID: 22166979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose and aging control the quiescence period that follows pancreatic beta cell replication.
    Salpeter SJ; Klein AM; Huangfu D; Grimsby J; Dor Y
    Development; 2010 Oct; 137(19):3205-13. PubMed ID: 20823063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure.
    Talchai C; Xuan S; Lin HV; Sussel L; Accili D
    Cell; 2012 Sep; 150(6):1223-34. PubMed ID: 22980982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice.
    Levitt HE; Cyphert TJ; Pascoe JL; Hollern DA; Abraham N; Lundell RJ; Rosa T; Romano LC; Zou B; O'Donnell CP; Stewart AF; Garcia-Ocaña A; Alonso LC
    Diabetologia; 2011 Mar; 54(3):572-82. PubMed ID: 20936253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overnutrition in the early postnatal period influences lifetime metabolic risk: Evidence for impact on pancreatic β-cell mass and function.
    Burton JJ; Alonso LC
    J Diabetes Investig; 2024 Mar; 15(3):263-274. PubMed ID: 38193815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia.
    Viggiano D
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noncanonical CDK4 signaling rescues diabetes in a mouse model by promoting β cell differentiation.
    Stamateris RE; Landa-Galvan HV; Sharma RB; Darko C; Redmond D; Rane SG; Alonso LC
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37712417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta cell dysfunction induced by bone morphogenetic protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding.
    Urizar AI; Prause M; Ingerslev LR; Wortham M; Sui Y; Sander M; Williams K; Barrès R; Larsen MR; Christensen GL; Billestrup N
    Cell Death Dis; 2023 Jul; 14(7):399. PubMed ID: 37407581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of subtotal pancreatectomy and long-term glucose and lipid overload on insulin secretion and glucose homeostasis in minipigs.
    Goutchtat R; Quenon A; Clarisse M; Delalleau N; Coddeville A; Gobert M; Gmyr V; Kerr-Conte J; Pattou F; Hubert T
    Endocrinol Diabetes Metab; 2023 Jul; 6(4):e425. PubMed ID: 37144278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling pathways that regulate adaptive β-cell proliferation for the treatment of diabetes.
    Shirakawa J
    J Diabetes Investig; 2023 Jun; 14(6):735-740. PubMed ID: 36871280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Strategies Targeting Pancreatic Islet β-Cell Proliferation, Regeneration, and Replacement.
    Goode RA; Hum JM; Kalwat MA
    Endocrinology; 2022 Nov; 164(1):. PubMed ID: 36412119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-Cell RNA Sequencing Reveals a Role for Reactive Oxygen Species and Peroxiredoxins in Fatty Acid-Induced Rat β-Cell Proliferation.
    Vivoli A; Ghislain J; Filali-Mouhim A; Angeles ZE; Castell AL; Sladek R; Poitout V
    Diabetes; 2023 Jan; 72(1):45-58. PubMed ID: 36191509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting pancreatic β cells for diabetes treatment.
    Jain C; Ansarullah ; Bilekova S; Lickert H
    Nat Metab; 2022 Sep; 4(9):1097-1108. PubMed ID: 36131204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged insulin-induced hypoglycaemia reduces ß-cell activity rather than number in pancreatic islets in non-diabetic rats.
    Jensen VFH; Mølck AM; Nowak J; Fels JJ; Lykkesfeldt J; Bøgh IB
    Sci Rep; 2022 Aug; 12(1):14113. PubMed ID: 35982111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Overfeeding-Induced Obesity Mouse Model Reveals Necessity for Sin3a in Postnatal Peak β-Cell Mass Acquisition.
    Bartolomé A; Ravussin Y; Yu J; Ferrante AW; Pajvani UB
    Diabetes; 2022 Nov; 71(11):2395-2401. PubMed ID: 35944274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.